Insulin Lispro Market Growth Accelerated by Increased Need for Diabetes Management


 Insulin lispro is a fast-acting insulin analog that helps manage blood glucose levels in patients with diabetes by mimicking the pharmacodynamics of naturally secreted insulin. Used in conjunction with oral medications or other insulin therapies, insulin lispro provides tighter glycemic control and improved post-meal blood sugar control compared to regular human insulin. The global Insulin Lispro Market is estimated to be valued at US$ 7.32 Bn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The growth of the Insulin Lispro Market is accelerating due to the increased need for diabetes management among the growing diabetic patient population globally. According to the International Diabetes Federation, around 537 million adults were living with diabetes in 2021 worldwide and the number is projected to rise to 643 million by 2030 and 783 million by 2045. The growing prevalence of diabetes has increased the demand for diabetes management drugs including insulin lispro. Moreover, advancement in insulin delivery methods such as insulin pens and pumps with improved convenience and efficacy compared to vials and syringes are further fueling the demand of insulin lispro.

Segment Analysis
The global insulin lispro market is dominated by the short-acting insulin segment. This is because short-acting insulin lispro offers a number of advantages over regular human insulin. Insulin lispro mimics the time action of naturally secreted insulin more closely and has a faster onset of action compared to regular human insulin. It also has a shorter duration of action, which makes it more suitable for administration before or during meals. All of these properties make short-acting insulin lispro preferable for patients requiring intensified insulin therapy.

Key Takeaways
The global insulin lispro market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 7.32 Billion by 2024.

Regional analysis: North America holds the largest share in the global insulin lispro market owing to rising prevalence of diabetes and growing demand for advanced treatment options in the region. Within North America, the U.S. accounts for the majority share due to presence of advanced healthcare infrastructure and availability of reimbursement schemes for diabetes care.

Key players operating in the insulin lispro market are Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Merck & Co., Inc., Pfizer Inc., Hoffmann-La Roche Ltd., AstraZeneca PLC, Johnson & Johnson Services, Inc., Biocon Limited, Mylan N.V., Boehringer Ingelheim International GmbH, Wockhardt Ltd., Lupin Pharmaceuticals, Inc., Bioton S.A., Gan & Lee Pharmaceuticals and Ypsomed AG. Eli Lilly and Company holds the leading market position as it is the pioneer in development of insulin lispro under the brand name of Humalog.
_________________________________________________________________________

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more